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Asperger syndrome and multiple
endophenotypes relevant to autism
Varun Warrier1*, Simon Baron-Cohen1,2 and Bhismadev Chakrabarti1,3*Abstract
Background: Autism spectrum conditions (ASC) are associated with deficits in social interaction and communication,
alongside repetitive, restricted, and stereotyped behavior. ASC is highly heritable. The gamma-aminobutyric acid
(GABA)-ergic system has been associated consistently with atypicalities in autism, in both genetic association and
expression studies. A key component of the GABA-ergic system is encoded by the GABRB3 gene, which has been
previously implicated both in ASC and in individual differences in empathy.
Methods: In this study, 45 genotyped single nucleotide polymorphisms (SNPs) within GABRB3 were tested for
association with Asperger syndrome (AS), and related quantitative traits measured through the following tests: the
Empathy Quotient (EQ), the Autism Spectrum Quotient (AQ), the Systemizing Quotient-Revised (SQ-R), the Embedded
Figures Test (EFT), the Reading the Mind in the Eyes Test (RMET), and the Mental Rotation Test (MRT). Two-loci,
three-loci, four-loci haplotype analyses, and one seven-loci haplotype analysis were also performed in the AS
case–control sample.
Results: Three SNPs (rs7180158, rs7165604, rs12593579) were significantly associated with AS, and two SNPs
(rs9806546, rs11636966) were significantly associated with EQ. Two SNP-SNP pairs, rs12438141-rs1035751 and
rs12438141-rs7179514, showed significant association with variation in the EFT scores. One SNP-SNP pair,
rs7174437-rs1863455, was significantly associated with variation in the MRT scores. Additionally, a few haplotypes,
including a 19 kb genomic region that formed a linkage disequilibrium (LD) block in our sample and contained several
nominally significant SNPs, were found to be significantly associated with AS.
Conclusion: The current study confirms the role of GABRB3 as an important candidate gene in both ASC and
normative variation in related endophenotypes.
Keywords: Asperger syndrome, Autism spectrum conditions, Empathy, Embedded Figures Test, Mental Rotation Test,
GABA receptorBackground
Autism spectrum conditions (ASC) are neurodevelopmental,
and are characterized by impairments in social interaction
and communication alongside unusually narrow interests
and repetitive behavior [1]. ASC are highly heritable,
although environmental and epigenetic factors also* Correspondence: vw260@medschl.cam.ac.uk; b.chakrabarti@reading.ac.uk
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reproduction in any medium, provided the orcontribute [2,3], and they affect 1% of the population [4].
Previous genetic research has largely focused on those in-
dividuals who also have learning difficulties. Asperger syn-
drome (AS) is a subgroup of ASC, and individuals with
AS have no speech or cognitive delays [5].
Although no single gene accounts for all of the
variation in the autism spectrum, several lines of evidence
points to a common theme of neural development across
genetic studies of autism. Genes involved in early brain
development (including genes involved in synapse formation
and stabilization, and those involved in neurotransmissionLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sistently with autism [6-8]. The gamma-aminobutyric acid
(GABA)-ergic system plays a crucial role in early neural de-
velopment. Both genetic association and gene expression
studies suggest a key role for the GABA-ergic system
in autism [9-11]. Specifically, variation in the GABRB3
gene in humans has been previously implicated in both
empathy [12] and ASC [13-16]. The first study to associate
variants in GABRB3 with ASC identified a statistically
significant association between the marker 155CA-2 and
individuals with ASC, using a multiple transmission
disequilibrium test on 140 families [17]. This was replicated
in 80 autism families [13]. Copy number variations and
other chromosomal abnormalities at the GABRB3 locus
have also been reported in individuals with ASC [14,18].
Variation in GABRB3 is also associated with tactile
sensitivity, which is atypical in some individuals with ASC
[19]. Gabrb3 knockout mice exhibit deficits in social
behavior and constitute a potential mouse model for
autism [20]. GABRB3 encodes the B3 subunit of the
GABAA receptor. GABAA receptor is an ionotropic,
ligand-gated receptor, which is part of the inhibitory
synapses in the adult brain, and selectively conducts Cl-
ions. During development, GABRB3 is an important
molecule for neuronal growth and differentiation, and
mediates excitatory signaling [21,22].
In the present study we tested the importance of
GABRB3 as a candidate gene in AS and in six potential
endophenotypic measures of the autistic spectrum: three
self-report measures (autistic traits, empathy, systemizing)
and three performance measures (emotion recognition,
attention to detail, and spatial processing).
The self-report measures used were as follows. The
Autism Spectrum Quotient (AQ) is a measure of autistic
traits. An AQ score above 32 is a predictor of ASC [23],
and AQ scores show significant heritability in a general
population sample [24]. Empathy was measured using
the Empathy Quotient (EQ) [25]. On average, individuals
with a diagnosis of AS will score significantly lower than
controls on the EQ [25]. Several lines of research have
suggested that individuals with ASC have difficulties with
empathy, especially cognitive empathy [26]. Empathy in
humans has a partly genetic basis [27,28]. Systemizing was
measured using the Systemizing Quotient-Revised (SQ-R),
in which individuals with AS score higher than controls
[27,28]. Family genetic studies suggest that systemizing is
part of the broader autistic phenotype in first-degree
relatives of individuals with autism [29,30]. Although
largely independent of each other, the EQ and the
SQ-R predict scores on the AQ [31].
The performance measures were as follows. Complex
emotion recognition ability was measured through the
Reading the Mind in the Eyes test (RMET). This is an
adult test of social sensitivity/cognitive empathy, in whichindividuals are shown photos of the eye region, and
required to choose which word best represents what the
person in the photograph is feeling or thinking [32]. On
average, people with ASC score significantly lower than
controls, and parents and siblings of people with ASC also
show mild deficits in this test. Performance is normally
distributed in the population, and scores on this test
show a high degree of familiality [33]. Attention to
detail was measured using the Embedded Figures Test
(EFT), in which participants are asked to locate a target
shape embedded within a complex pattern [34]. Individuals
with ASC score above average [34], and scores on the EFT
are also associated with high familiality [35]. Spatial
processing was measured using the Mental Rotation
Test (MRT), in which individuals are asked to process
rotated pairs of letters and identify if the letter-pairs
are identical to or mirror images of each other. Individuals
with ASC perform better than controls on the MRT [36],
and there is some evidence to suggest heritability of mental
rotation ability [37].
To our knowledge, this is only the second study investi-
gating the role of GABRB3 specifically in AS, and
variations in EQ, AQ, EFT, and RMET scores. The first
study (also from our group) found a genetic association
between a variant in GABRB3 and empathy [12]. In the
current study, we aimed to replicate and extend the findings
of the first study in a new sample of volunteers. We hypoth-
esized an association between the variants in GABRB3 with
both AS and associated quantitative traits. Two separate
experiments were conducted to test the role of GABRB3 in
adults with AS. The first tested if any of 45 single nucleotide
polymorphisms (SNPs) showed an association with a
diagnosis of AS, using a case–control design. The second
experiment tested for association of these SNPs with any
of the quantitative endophenotypic measures described
above, in the control population.
Methods
Ethics approval
The study was approved by the Cambridge Psychology
Research Ethics Committee and by the NHS Research
Ethics Committee (UK). All participants provided written
consent to take part in this study. All research adhered to
the Declaration of Helsinki.
Participants
All individuals involved in the current study were of
Caucasian ancestry. Individuals free of any psychiatric
or neurological disorders were recruited as controls
by advertisements.
In total, 530 individuals participated in the case–control
association study for AS. Of these, 412 (185 male,
227 female) individuals with an AQ score below 24 formed
the controls, and 118 individuals with a DSM-IV (Diagnostic
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or ICD-10 (International Classification of Diseases, Tenth
Revision)–diagnosis of AS (74 male, 44 female) formed the
cases. All cases were recruited through our online database,
and were diagnosed with AS by independent clinicians
(psychiatrists or clinical psychologists only) from established
clinics. The mean AQ score of the cases was 35.6 ± 8.9. This
is very close to the previously reported mean of 35.6 ± 6.63
for people with AS [21]. The mean AQ score in the general
population is 16.4, with a standard deviation of 6.3 [38].
Taking this into consideration, we selected only individuals
with an AQ score of below 24 as controls to ensure a
balanced representation of individuals from two ends
of the autistic trait continuum.
All the quantitative trait studies were conducted only in
participants without a clinical diagnosis of AS. Individuals
were invited to participate in online assessment of all six
measures investigated in the study. In total, 412 individuals
participated in the association study for the AQ, 413 for
the EQ, and 414 for the SQ-R. The same individuals who
were the controls in the case–control study participated in
the association study for AQ. Additionally, 245 individuals
participated in the association study for the MRT, REMT,
and EFT.
Phenotypic scores for each measure and participant
information are provided in Table 1.
SNP selection
In total, 45 SNPs were selected to provide maximal coverage
through linkage disequilibrium (LD) of the GABRB3
gene region on chromosome 15 from 26802824 bp to
27200217 bp (GRCH37.p10 Primary Assembly, NCBI).
SNPs were chosen to ensure that inter-SNP distance was less
than 10 kb. The choice of SNPs was constrained byTable 1 Phenotype measures and participant information
Participants Case–control AQa EQ
Cases Controlsa
Numbers
Total 118 412 412 413
Male 74 185 185 209
Female 44 227 227 204
Trait score, mean ± SD
Overall 35.6 ± 8.9c 14.9 ± 5.0c 14.9 ± 5.0 41.5 ±
Male 35.1 ± 8.7c 16.0 ± 4.4c 16.0 ± 4.4 36.8 ±
Female 36.6 ± 8.8c 13.9 ± 5.1c 13.9 ± 5.1 45.6 ±
Range 7 to 50 2 to 23 2 to 23 2 to 2
Abbreviations: AQ, Autism Spectrum Quotient; EFT, Embedded Figures Test; EQ, Emp
Test; SQ-R, Systemizing Quotient, Revised.
aThe same individuals participated in the case–control and AQ quantitative trait stu
bThe same individuals participated in REMT, EFT, and MRT.
cTrait scores for case–control study are the Adult Autism Spectrum Quotient scoresthe availability of the ABI TaqMan assays that were
used for genotyping. Nine SNPs (rs12437672, rs1432007,
rs12905535, rs737098, rs2114485, rs1426217, rs890317,
rs7171512, rs8026392) are TagSNPs as indicated by the
HapMap genome browser, release 27. Although the SNPs
covered most of the genetic region, they did not
completely flank the gene. Of the 45 SNPs, rs3212331
(Chr15: 27014769) is the most upstream, and rs2114485 is
the most downstream (Chr15: 26802824) in the orientation
of the gene. For the selected SNPs, the minor allele fre-
quency (MAF) was above 0.05 in the CEU (Utah Residents
with Northern and Western European Ancestry) popula-
tion as calculated from the dbSNP database (http://www.
ncbi.nlm.nih.gov/projects/SNP/). DNA was extracted from
buccal samples, anonymized, and genotyped using the same
protocol described in our first study [12]. No SNPs deviated
significantly from Hardy-Weinberg equilibrium. Total
genotyping rate across all the experiments was greater
than 98%.Association tests
The two experiments were as follows.Case–control association study for AS
SNP association tests were conducted for all SNPs on all
cases with AS (n = 118), and controls (n = 412, with an
AQ score below 24). SNP-SNP interaction tests were
then carried out on this sample. In total, 990 possible
SNP-SNP combinations (45 × 45) were tested for associ-
ation using logistic regression, and significant SNPs were
additionally checked for LD between them. Interactions
were reported to be significant if the SNP pairs were not
in LD.SQ-R RMETb EFTb MRTb
414 245 245 245
210 122 122 122
204 123 123 123
12.3 60.3 ± 20.6 27.1 ± 3.2 11.6 ± 1 16.8 ± 2.6
12.4 63.9 ± 20.0 27.06 ± 3.2 11.7 ± 0.6 17.4 ± 2.1
12.3 56.5 ± 20.4 27.1 ± 3.2 11.6 ± 1.2 16.1 ± 2.9
4 11 to 139 17 to 34 2 to 12 7 to 20
athy Quotient; MRT, Mental Rotation Test; RMET, Reading the Mind in the Eyes
dies.
.
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Quantitative trait association studies were performed for
the AQ, SQ-R, EQ, ET, EFT and MRT. SNP association
tests on each of these quantitative traits were conducted
in controls only. The number of participants in each
experiment differed (Table 1). SNP-SNP interaction tests
were tested for association with each of the six quantitative
traits, for a total of 990 SNP combinations, and modeled
using linear regression. As in the previous experiment,
interactions were reported to be significant if the SNP
pairs were not in LD.Statistical analysis
All statistical analyses were performed using Plink version
1.07 (http://pngu.mgh.harvard.edu/~purcell/plink/) [39].
Bonferroni correction was implemented to correct for
multiple SNPs and phenotypes tested. A threshold of
significance (α) was calculated after both the corrections.
P-values were reported as significant if they were below
the α threshold.
The effective number of independent SNPs was estimated
using SNPSpD (http://genepi.qimr.edu.au/general/daleN/
SNPSpD/) [40]. For the SNP association studies the total
number of independent loci (after taking into account the
LD between SNPs) and the new α value was determined
for each test using SNPSpD. On average, the total number
of independent loci was calculated to be 30.5, although
this varied marginally between tests (because of small
differences in the number of individuals who completed
each quantitative measure). For SNP-SNP interaction, a total
of 990 possible SNP-SNP combinations was tested. However,
SNP-SNP interaction can be calculated accurately only
for independent loci. The total number of independent
SNP-SNP combinations was thus determined to be
465 (31 × 30)/2). The Bonferroni corrected α was set
to 0.000108.
Bonferroni correction was also used to correct for the
multiple phenotypes tested. Owing to differences in sam-
ples for the phenotypes tested the experiments were
broadly divided into three groups for correction.
Group 1 was the case–control association test for AS,
which had the largest sample size and was distinct
because of inclusion of cases (Experiment 1). In this
sample, only one phenotype (that is, clinical diagnosis)
was tested, and hence correction for multiple phenotypes
was not implemented.
Experiment 2 consisted of two largely distinct samples.
The first of these samples, group 2, comprised the AQ, EQ
and SQ-R, as more than three-quarters of the participants
had participated in two or more of these tests. However, as
all three phenotypes had a high degree of correlation
between them, these were not treated as truly independent
observations. Because Bonferroni correction tends to beover-corrective when traits are correlated, we did not use
this for multiple phenotypes in this group.
The second sample within experiment 2, group 3, com-
prised the three performance-based tests (the RMET, EFT,
and MRT) and was a subsample of group 2.
In total, 245 individuals took part in all three tests. There
was little correlation between the phenotype scores
for these tests in our sample. Bonferroni correction
was implemented for this group. The α value for SNP
association tests and SNP-SNP interaction tests derived
from SNPSpD was divided by 3 to get the final α value. For
SNP-SNP interaction tests on the performance-based tests,
the final α value was 0.000036 (or 0.000108 divided by 3).
Haplotype analysis
Haplotype analysis was performed for case–control AS
dataset using Plink. Haplotypes were phased using the
E-M algorithm, and global or omnibus two-loci, three-loci,
and four-loci haplotype analyses were performed using
logistic regression on Plink. Additionally, one large LD block,
which is 19 kb long from rs7174437 to rs7180158,
was considered for haplotype analysis. There are nine
SNPs located in this region, including all three significant
SNPs and three nominally significant SNPs for the
case–control AS association study. P-values were corrected
for family-wise error rates using permutation correction
with 50,000 permutations, and the α value for significance
was kept at 0.05.
LD analyses and SNP annotation
LD values between SNPs of interest in the HapMap
CEU population data were calculated using SNAP
(http://www.broadinstitute.org/mpg/snap/) [41]. LD values
between SNPs in our sample were calculated using Plink.
LD values have been reported using R2 rather than
D′ as R2 takes into account allele frequencies in popula-
tions. LD plots for the sample studied were created using
Haploview [42].
Integrated putative functional scores for the SNPs
tested were obtained using both the F-SNP server
(http://compbio.cs.queensu.ca/F-SNP) [43] and FastSNP
(http://fastsnp.ibms.sinica.edu.tw/pages/input_Candidate
GeneSearch.jsp) [44]. SNPnexus (http://www.snp-nexus.
org/) [45] was used to investigate SNP conservation and
structural variants in the locus investigated. Haploreg
(http://www.broadinstitute.org/mammals/haploreg/) [46]
was used to check for histone markers, conservation scores,
and DNAse hypersensitivity sites for the SNP of interest
and other SNPs in high LD (R2 > 0.8). This was also
manually cross-checked using the UCSC Genome Browser
(http://genome.ucsc.edu/) [47]. Finally, the Genetic
Association Database (http://geneticassociationdb.nih.
gov/) [48] was used to check for reports of any pre-
vious associations for the significant SNPs.
Table 2 GABRB3 SNP association results for AS and the six quantitative endophenotypes investigated
SNP SNP position AS case–control P value
OR P value AQ EQ SQ-R EFT REMT MRT
rs2114485 26802824 0.9369 0.704 0.6105 0.6514 0.6369 0.6719 0.1518 0.9454
rs11631940 26806814 0.8902 0.5088 0.6759 0.8435 0.1997 0.8645 0.8271 0.4787
rs1432007 26810689 1.127 0.4205 0.7813 0.6526 0.5193 0.7481 0.2376 0.7725
rs1426217 26821125 1.082 0.5975 0.439 0.4008 0.5922 0.5827 0.6484 0.5826
rs10519563 26823404 1.096 0.6204 0.8042 0.1096 0.1448 0.3941 0.9824 0.2969
rs12440905 26826281 1.584 0.3943 0.9656 0.2318 0.9096 0.5663 0.6207 0.5445
rs17646555 26837651 1.089 0.749 0.7359 0.0351 0.7584 0.6143 0.2616 0.1865
rs12437672 26838405 1.016 0.9246 0.6538 0.3636 0.4328 0.8751 0.675 0.4629
rs1582760 26853487 1.114 0.6609 0.902 0.2335 0.7375 0.4951 0.4093 0.3209
rs2873027 26867409 0.9804 0.8947 0.4164 0.7438 0.4436 0.3401 0.996 0.7369
rs12438141 26870602 1.094 0.6625 0.2593 0.05641 0.7694 0.04683 0.1429 0.004928
rs10873636 26888978 0.8377 0.2985 0.01893a 0.01765a 0.04946a 0.8912 0.05818 0.02446
rs11636966 26893028 0.9915 0.9547 0.06219 0.000594a 0.8307 0.7713 0.5205 0.7296
rs9806546 26893386 0.7572 0.188 0.06427 0.001469 0.009834a 0.6132 0.4449 0.3145
rs8023959 26894305 1.034 0.887 0.1065 0.7408 0.8473 0.3852 0.05979 0.06356
rs7179514 26895324 1.028 0.8525 0.107 0.002318a 0.5474 0.3509 0.5521 0.1739
rs7171512 26906345 0.9611 0.7976 0.3705 0.01302a 0.3096 0.7664 0.1414 0.9829
rs12442889 26917100 1.041 0.8066 0.3348 0.2381 0.3188 0.8606 0.6945 0.1025
rs1367959 26917158 1.178 0.315 0.7905 0.001742a 0.1215 0.02745 0.2206 0.05204
rs1863455 26918169 0.8474 0.4769 0.2206 0.5058 0.4483 0.3591 0.005442 0.8047
rs890317 26922201 0.8293 0.2741 0.9942 0.1927 0.9031 0.09281 0.887 0.8351
rs11161329 26926710 0.8283 0.2203 0.5383 0.07182 0.6331 0.02263 0.07253 0.7137
rs12593482 26933545 1.119 0.7621 0.7125 0.04769a 0.2482 0.6505 0.9041 0.6601
rs1035751 26943796 0.8033 0.4228 0.531 0.8884 0.9924 0.1161 0.9053 0.4785
rs7181473 26950087 1.018 0.9072 0.4267 0.5739 0.9399 0.7201 0.8816 0.6508
rs17117279 26952672 0.8777 0.5218 0.3016 0.09375 0.6948 0.1173 0.2397 0.4522
rs1426224 26953091 0.984 0.9632 0.3725 0.1801 0.2826 0.5186 0.1248 0.4864
rs1549482 26953764 1.073 0.7015 0.9659 0.6341 0.6026 0.072 0.4522 0.3501
rs4906896 26960426 1.354 0.04067a 0.001682a 0.01946a 0.8831 0.05366 0.03463a 0.126
rs737098 26967170 0.7071 0.04886a 0.1189 0.1006 0.03769a 0.9156 0.5102 0.6054
rs2315904 26967522 0.8293 0.4539 0.4212 0.5888 0.08328 0.1348 0.3303 0.1788
rs1863456 26974032 1.006 0.9703 0.116 0.06622 0.7006 0.2814 0.6925 0.271
rs2162241 26976782 0.7075 0.02707a 0.2351 0.1778 0.2413 0.5519 0.5273 0.8923
rs7180158b 26978238 2.15 0.000358a 0.4416 0.2842 0.01907a 0.3974 0.7486 0.124
rs8026932b 26978906 1.263 0.5769 0.006922a 0.9863 0.7881 0.6083 0.1999 0.9726
rs6576602b 26982080 1.46 0.03347a 0.189 0.3375 0.00998a 0.05174 0.4184 0.01776a
rs890318b 26982378 0.745 0.2896 0.2458 0.8865 0.3377 0.08322 0.4733 0.1141
rs12593579b 26988132 1.96 0.000668a 0.5066 0.335 0.03631a 0.3711 0.74 0.2056
rs8038471b 26990651 1.154 0.3372 0.08613 0.01078a 0.9937 0.3891 0.8799 0.6707
rs12905535b 26992166 0.6169 0.005747a 0.08597 0.03931a 0.04997a 0.283 0.4318 0.07415
rs7165604b 26994456 2.452 0.000451a 0.1189 0.1297 0.1982 0.278 0.8782 0.09043
rs7174437b 26997923 2.022 0.01567a 0.1185 0.02142a 0.5118 0.4765 0.8321 0.4211
rs7178713 27002886 0.6789 0.01877a 0.4842 0.1292 0.1468 0.5308 0.1201 0.1008
Warrier et al. Molecular Autism 2013, 4:48 Page 5 of 11
http://www.molecularautism.com/content/4/1/48
Table 2 GABRB3 SNP association results for AS and the six quantitative endophenotypes investigated (Continued)
rs8026392 27008723 0.8825 0.4244 0.05513 0.02792a 0.4595 0.4105 0.6825 0.3217
rs3212331 27014769 0.896 0.53 0.6579 0.7116 0.6821 0.2821 0.8648 0.5415
Abbreviations: AQ Autism Spectrum Quotient, EFT Embedded Figures Test, EQ Empathy Quotient, MRT Mental Rotation Test, RMET Reading the Mind in the Eyes
Test, SQ-R Systemizing Quotient, Revised, SNP single nucleotide polymorphism.
aNominally significant P-values (P < 0.05).
bSNPs found in haplotype block 7 (as referred to in Figure 2).
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SNP associations
Case–control association
Ten SNPs were nominally associated with AS (Table 2). Of
these, rs7180158, rs7165604, and rs12593579 survived
Bonferroni correction (Table 3). All three SNPs are lo-
cated in the intron 4 of the GABRB3 gene (Figure 1). In our
sample, all three SNPs were found to be a part of an LD
block as calculated by Haploview (Figure 2). Nine SNPs form
the LD block. Three of the SNPS (rs7180158, rs7165604, and
rs12593579) were significant after Bonferroni correction
and another three of these SNPs (rs12905535, rs7174437,
rs6576602) were nominally significant in the AS association
study. For the LD structure for GABRB3 in the HapMap
CEU population, see Additional file 1. There were no
significant SNP-SNP interactions for the case–control
analysis (see Additional file 2).Table 3 Significant haplotypes for case–control (Asperger
syndrome)
No of
SNPs
SNP haplotype FWER corrected
P-value
2 rs1863456-rs2162241 0.03284
2 rs2162241-rs7180158 0.03882
2 rs7180158-rs8026932 0.0304
2 rs6576602-rs890318 0.03576
2 rs890318-rs8038471 0.021
2 rs12593579-rs8038471 0.00582
2 rs12905535-rs7165604 0.01768
3 rs4906896-rs737098-rs2315904 0.02002
3 rs1863456-rs2162241-rs7180158 0.02438
3 rs8026932-rs6576602-rs890318 0.0209
3 rs890318-rs12593579-rs8038471 0.0145
3 rs12593579-rs8038471-rs12905535 0.01192
3 rs8038471-rs12905535-rs7165604 0.03052
4 rs7180158-rs8026932-rs6576602-rs890318 0.03832
4 rs8026932-rs6576602-rs890318-rs12593579 0.04774
4 rs6576602-rs890318-rs12593579-rs8038471 0.02428
4 rs890318-rs12593579-rs8038471-rs12905535 0.01002
4 rs12593579-rs8038471-rs12905535-rs7165604 0.0454
9 rs7180158-rs8026932-rs6576602-rs890318-
rs12593579-rs8038471-rs12905535-
rs7165604-rs7174437
0.00534
Abbreviations: FWER family-wise error rate, SNP single nucleotide polymorphism.Quantitative trait associations
Two SNPs were nominally associated with the RMET,
seven were nominally associated with the SQ-R, and 13
were nominally associated with the EQ, while three SNPs
each were nominally associated with the AQ, EFT, and
MRT (Table 2). Two SNPs, rs11636966 and rs9806546,
survived Bonferroni correction for the EQ (see Table 4);
both of these SNPs are located in intron 5 of the GABRB3
gene (Figure 1). No SNP was nominally significant across
all the six measures. Two SNP-SNP interactions were
found to be significantly associated with the EFT after
Bonferroni correction (Table 4). These were: rs12438141-
rs1035751 (R2 = 0.017) and rs12438141-rs7179514
(R2 = 0.001) (Table 4, Figure 1). One SNP-SNP interaction,
rs7174437-rs1863455, was found to be significant for the
MRT (R2 = 0.003) (Table 4, Figure 1). Neither of the SNPs
was nominally significant in the SNP association study for
the MRT. There were no significant SNP-SNP interactions
for any of the other traits tested (see Additional file 3).
Haplotype analysis
Seven two-loci haplotypes, six three-loci haplotypes, five
four-loci haplotypes, and one nine-loci haplotype, which
spanned a 19 kb entire LD block (rs7180158-rs7174437;
Chr15:26978238–26997923), were significant after per-
mutation correction (Table 3; see Additional file 4).
All the haplotypes except two two-loci haplotypes
[rs1863456-rs2162241 (Chr15: 26974032–26976782) and
rs2162241-rs7180158 (Chr15: 26976782–26978238)] and
two three-loci haplotypes (rs4906896-rs737098-rs2315904
(Chr15: 26960426–26967522) and rs1863456-rs2162241-
rs7180158 (Chr15: 26974032–26978238)) are part of the
19 kb region. The four haplotypes not a part of this
region lie immediately upstream (see Figure 2) The
omnibus nine-loci haplotype had a corrected P-value
of 0.00534, indicating that the genomic region as a
whole (Figure 2) is associated with AS in our sample.
Discussion
In this study, we tested multiple common variants in
GABRB3 for association with AS and related endopheno-
types in a general population sample. To our knowledge,
this is the first study to incorporate such a comprehensive
group of phenotypes (including clinical diagnosis,
self-report questionnaires, and observational measures on
both social and non-social aspects of autistic cognition).
Figure 1 Schematic diagram of GABRB3 showing significant single nucleotide polymorphisms (SNPs). Black lines represent exons. Red
lines represent the significant SNPs. There are 12 exons in GABRB3, which are shown.
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http://www.molecularautism.com/content/4/1/48Nine SNPs were nominally associated with AS, of which
three (rs7180158, rs7165604, rs12593579) retained their
significance after Bonferroni correction. All three SNPs
are located in a 19 kb genomic region that forms an LD
block in our sample. The entire block was found to
be associated with AS when tested for global haplotype
association. For the EQ, thirteen SNPs were nominally
significant, of which two (rs9806546, rs11636966) remained
significant after Bonferroni correction. Two SNP-SNP
interactions were significant for the EFT (rs12438141-
rs1035751 and rs12438141-rs7179514) and one for the
MRT (rs7174437-rs1863455) after Bonferroni correction.
None of the SNPs was located in regions of common
structural variations, CpG islands, or affected micro RNA
binding sites, as calculated by SNPnexus and the UCSC
Genome Browser.
The three SNPs that were significant in AS case–control
studies are located in intron 4, within a region of 16,218Figure 2 Linkage disequilibrium (LD) structure of GABRB3 for the Asp
region investigated in the AS case–control dataset (412 controls and 118 c
nucleotide polymorphisms (SNPs) that were genotyped have been plottedbase pairs. In our sample, they were found to be a part of a
shared 19 kb LD block, which is also associated with AS.
This genomic region extends from rs7180158 (Chr15:
26978238, dbSNP) to rs7174437 (Chr15: 26997923, dbSNP)
in intron 4, and is 19,905 bp downstream of exon 3 and
16,326 bp upstream of exon 4. When queried in FastSNP,
rs12593579 was suggested to disrupt an enhancer region.
Both rs7165604 and rs12593579 are found in putative
transcription regulatory sites according to F-SNP. Further,
according to Haploreg, these SNPs disrupt transcription
factor binding sites either directly or through common
variants in high LD. The two SNPs significantly associated
with the EQ are located in intron 5, and are a mere 358 bp
apart. However, they are not in significant LD either in the
CEU population (R2: 0.182; see Additional file 1: Table S1) or
in our sample (R2 = 0.157) (see Additional file 1: Figure S2).
It is hence likely that the effect of the SNPs have
been independently measured, although this does noterger syndrome (AS) case–control dataset. LD structure of the
ases), as plotted on Haploview is shown. In this graph, 45 single
. They fall into eight LD blocks.
Table 4 Significant SNPs and SNP-SNP pairs
SNP or SNP-SNP
interaction
Phenotype P values
(uncorrected)a
Minor allele/major
alleleb
MAF (HapMap
CEPH)c
Frequency of minor allele χ2
Cases Controls
rs7180158 AS 3.58E-04 A/G A = 0.24 0.1624 0.08272 12.74
rs7165604 AS 4.51E-04 C/T C = 0.17 0.1174 0.05145 12.31
rs12593579 AS 6.68E-04 C/A C = 0.21 0.194 0.1093 11.58
rs11636966 EQ 5.94E-04 T/C T = 0.22 NA NA NA
rs9806546 EQ 1.47E-03 A/G A = 0.40 NA NA NA
rs12438141-rs1035751 EFT 7.59E-06 C/T - A/G T = 0.13, G = 0.06 NA NA NA
rs12438141-rs7179514 EFT 5.21E-06 C/T - C/G T = 0.13, G = 0.31 NA NA NA
rs7174437-rs1863455 MRT 1.58E-05 C/T - C/T C = 0.12, C = 0.08 NA NA NA
Abbreviations: AQ, Autism Spectrum Quotient; AS, Asperger syndrome; EFT, Embedded Figures Test; EQ, Empathy Quotient; MRT, Mental Rotation Test; NA, not
applicable; SNP, single nucleotide polymorphism.
aCorrected P-value threshold is 3.6 × 10-05.
bAlleles for SNP-SNP pairs have been provided in the order they are written.
cMAF for SNP-SNP pairs have been provided in the order they are written.
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http://www.molecularautism.com/content/4/1/48exclude the possibility that a single non-tested variant
situated close by is contributing to the effect seen at
the two SNPs. Genotyping all the variants in this
short region and testing them for association with the
EQ should be undertaken in a future study. The most
significantly associated SNP rs11636966 markedly alters
an En-1_2 binding site (Haploreg). There is considerable
evidence to suggest a role for proteins of the Engrailed
family in early neurodevelopment and ASC [49-52]. Both
these SNPs are also in high LD with several SNPs that
putatively alter other transcription factor binding sites. A
previous study from our laboratory [12] tested for associ-
ation between two SNPs in GABRB3 (rs2873027 and
rs11161335) with both AS and the EQ. Neither of the two
SNPs was significantly associated with AS, but rs2873027
was found to be associated with the EQ. In the current
study, only rs2873027 was included in the 45 SNPs
genotyped. rs2873027 was not significantly associated
with the EQ in the current study.
Two SNP-SNP interactions were found to contribute
to variation in the EFT scores. Three SNPs participate in
these interactions and none of them is in significant LD
with each other either in the CEU population sample or
in our sample (see Additional file 1: Table S1; see
Additional file 1: Figure S3). Two of these SNPs,
rs7179514 and rs1035751, are located in intron 5, while
rs12438141 is located in intron 6. According to both
FastSNP and F-SNP, rs1035751 and rs12438141 alter
transcription regulatory sites. All SNPs except rs1035751
disrupt regulatory motifs (Haploreg). A single SNP-SNP
interaction, rs1863455-rs7174437, was significantly associ-
ated with the MRT. rs1863455 is located in intron 5 and
rs7174437 in intron 4, and they are 79,754 bp apart. They
are not in significant LD (R2 = 0.003) (see Additional file 1:
Table S1) in the CEU population, and are not a part of an
LD block in our sample (see Additional file 1: Figure S3).Both the SNPs disrupt regulatory motifs (FastSNP, F-SNP,
and Haploreg). rs7174437 disrupts regulatory motifs of the
Sox family of transcription factors (Haploreg), which play a
pivotal role during development [53].
The putative functional annotation of the SNPs indicates
that a number of the significantly associated SNPs alter
GABRB3 transcription during and after embryonic devel-
opment either directly or via other variants that are in
high LD. Of the ten SNPs found to be significant, three
are in intron 4, six in intron 5, and one in intron 6.
GABRB3 has twelve exons (see Figure 1) and four
transcript variants in NCBI. Transcript variants 1 and
2 are more common at a cellular level, but neither of
them have exons 5 and 6. Transcript variant 3, which
has been described only at the transcript level, starts
from exon 5, whereas transcript variant 4, which has
been described at the protein level, starts from exon 6.
There are currently no studies describing the function of
these transcripts. It is possible that the variants in introns
4 and 5 act to regulate levels of these alternate transcripts.
Alternatively, the variants could also act as intronic
regulatory elements to alter the levels of transcript
variants 1 and 2. Cellular studies need to be performed to
validate either of these hypotheses.
We did not replicate the exact SNP association reported
by Chakrabarti et al. [12]. However, the inference in our
earlier paper was at the gene level (that is, the statistical
inference from the permutation analysis was that one or
more SNPs in the gene were significantly associated with
the phenotype, and not specifically for any SNP). The
current study replicates the association of GABRB3 with
empathy at the gene level, and provides evidence for the
association of GABRB3 with AS, the EFT, and the MRT.
A limitation of this study is the moderate sample size.
Replication of the results in a larger sample size is required
to validate the findings. Although no SNP was significant
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http://www.molecularautism.com/content/4/1/48across two or more traits, the experiments were not
completely independent as several individuals participated
in two or more experiments. Additionally, the low variance
in the phenotypic scores of EFT must be taken into account
when interpreting the results. To assess if the limited
variance was restricted to the genotyped sample, we
checked for EFT scores in a larger database. Both the
mean EFT score and standard deviation were similar
between the two datasets, indicating that the low variance
in the EFT scores in our sample was not an artifact.
Although none of the cases studied were formally
tested for IQ, an essential feature for the clinical diag-
nosis of AS is that individuals diagnosed as having AS or
high-functioning autism (as was the case for the ASC sam-
ple in our study) is that individuals have an IQ in the aver-
age range [54]. Average range is defined as two standard
deviations either side of the mean, so this would
mean an IQ of over 70. Further, it has been shown that IQ
and autistic traits show limited genetic covariance [55]. It
is therefore reasonable to infer that IQ differences are
unlikely to confound the conclusions drawn from the
current study. Finally, it is important to remember that
GABRB3 is not the sole gene that contributes to either AS
or the traits tested, and that other genes could act
either independently of or epistatically with GABRB3
to contribute to these complex phenotypes.Conclusions
We report novel associations of SNPs in GABRB3 with
AS, and normative variation in empathy. We did not
find any allelic association between SNPs in GABRB3
and the five other endophenotypes tested. A large 19 kb
LD block was also positively associated with AS in
our sample. We also found three intragenic SNP-SNP
interactions that are significantly associated with two
of the endophenotypes. Two SNP-SNP interactions were
associated with EFT, and one SNP-SNP interaction is
associated with MRT. This is the first study to specifically
test the association of such a large number of SNPs in
GABRB3 with AS, along with a comprehensive group of
endophenotypes.Additional files
Additional file 1: Linkage disequilibrium (LD) information for the
single nucleotide polymorphisms (SNPs) investigated. A table
presenting pairwise LD for the significant GABRB3 SNPs genotyped in the
HapMap CEU population. Three LD plots for the region investigated in 1)
the CEU population; 2) the cohort investigated for the Empathy Quotient
(EQ); 3) the cohort investigated for the Embedded Figures Test (EFT),
Mental Rotation Test (MRT) and Reading the Mind in the Eyes Test (RMET).
Additional file 2: GABRB3 SNP-SNP interaction results for case–control
(AS). AS, Asperger syndrome; SNP, Single nucleotide polymorphism.Additional file 3: GABRB3 SNP-SNP interaction results (P-values) for
the six quantitative traits investigated. SNP, Single nucleotide
polymorphism.
Additional file 4: GABRB3 case–control (AS) results for haplotype
analysis. AS, Asperger syndrome.
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